The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2012Effect of Tyrosine on Orthostatic Hypotension in Parkinson’s Disease
Objective/Rationale:
Orthostatic hypotension is a sudden drop in blood pressure (BP) when an individual changes position. Individuals with Parkinson’s disease (PD) commonly suffer from orthostatic... -
Rapid Response Innovation Awards, 2012Investigation of the Mechanisms Involved in Alpha-synuclein Secretion In Vivo
Objective/Rationale:
Extracellular alpha-synuclein appears to be central in the pathogenesis, and perhaps progression of PD. The mechanism(s) underling alpha-synuclein secretion are... -
MJFF Research Grant, 2012Consortium to Identify LRRK2 Modifiers of Age of Onset
Objective/Rationale:
We propose to design and complete a collaborative study that will bring together data and samples from subjects with LRRK2 mutations with the express goal of... -
MJFF Research Grant, 2012Targeting the Unfolded Protein Response (UPR) Transcription Factor XBP1 to Alleviate Neurodegeneration Triggered by Alpha-synuclein
Objective/Rationale:
Our general aim is to investigate the role of a specific component of a cellular stress response, known as the Unfolded Protein Response, in the development of Parkinson's disease... -
MJFF Research Grant, 2012Mechanisms of Cellular Regulation and Post-translational Modification of LRRK2
Promising Outcomes of Original Grant:
We have identified methods to increase or decrease the ratio of cytosolic LRRK2 compared to membrane-localized LRRK2 as well as methods to increase or decrease the... -
Alpha-synuclein Biology Challenge, 2012Alpha-synuclein Aggregation Leads to Loss of Functional Forms of the Protein and Toxicity
Objective/Rationale:
The protein alpha-synuclein has been linked to Parkinson’s disease (PD). The prevailing hypotheses state that this protein is directly toxic to neurons and thus the removal of...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.